This short article describes how Organovo is using a novel technology called bioprinting to produce liver and kidney tissues that could help reshape the way drugs are tested and organs are transplanted in our days. It also discusses the challenges and potential effects on society.
Advances in machine learning and artificial intelligence may now enable patients and providers to detects life-threatening illnesses earlier than ever. But much remains unknown about these rapidly evolving diagnostics. Can the FDA keep up while protecting public health in the era of big data?
The US Food and Drug Administration (FDA) takes steps to protect against threats to the pharmaceutical supply chain posed by extreme weather events.
Counterfeit drugs adversely impact both consumers and pharmaceutical companies. Can blockchain help solve this problem?
With its destructive power, Hurricane Maria revealed the fragility of the global pharmaceutical supply chain when it struck Puerto Rico, a major drug manufacturing hub, earlier this year. How can US regulatory bodies mitigate the impact climate change, and the resulting “super storms”, has on drug availability?
Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?